Cogenzia gentamicin topical: Phase III started

Innocoll began the double-blind, U.S. Phase III COACT-1 trial of Cogenzia given for 28 days in about 500 patients. Patients will receive systemic antibiotic therapy plus Cogenzia, a placebo sponge or ...